50
Participants
Start Date
December 14, 2016
Primary Completion Date
July 30, 2021
Study Completion Date
July 30, 2021
OBIZUR
Treating physician will determine treatment regimen and frequency of laboratory and clinical assessments according to routine clinical practice.
AKH - Medizinische Universität Wien, Vienna
Vivantes Klinikum im Friedrichshain, Berlin
Azienda Ospedaliera Nazionale Santi Antonio e Biagio e Cesare Arrigo, Alessandria
Istituto Clinico Humanitas, Rozzano
Fondazione IRCCS Policlinico San Matteo, Pavia
Duke University Medical Center, Durham
Medizinische Hochschule Hannover, Hanover
University of Florida - Shands, Gainesville
Cleveland Clinic, Cleveland
University Hospitals Cleveland Medical Center, Cleveland
Henry Ford Hospital, Detroit
Universitaetsklinikum Bonn, Bonn
Klinikum der Johann Wolfgang Goethe-Universitaet, Frankfurt
CHU de Rouen - Hôpital Charles Nicolle, Rouen
The University of Texas Health Science Center at Houston, Houston
Azienda Ospedaliera Pugliese Ciaccio, Catanzaro
Azienda Ospedaliero Universitaria Policlinico Paolo Giaccone, Palermo
Universitaetsklinikum Carl Gustav Carus TU Dresden, Dresden
Policlinico Universitario Agostino Gemelli, Roma
Umberto I Pol. di Roma-Università di Roma La Sapienza, Rome
Radboud University Medical Centre, Nijmegen
University Hospital Birmingham, Birmingham
St James's University Hospital, Leeds
Royal Free Hospital, London
Churchill Hospital, Oxford
Southampton General Hospital, Southampton
Baxalta Innovations GmbH, now part of Shire
INDUSTRY
Baxalta now part of Shire
INDUSTRY